TITLE

The Effect of Heparan Sulfate Application on Bone Formation during Distraction Osteogenesis

AUTHOR(S)
Gdalevitch, Marie; Kasaai, Bahar; Alam, Norine; Dohin, Bruno; Lauzier, Dominique; Hamdy, Reggie C.
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Bone morphogenetic proteins (BMPs) are recognized for their ability to induce bone formation in vivo and in vitro. Their osteogenic and osteoinductive properties are tightly regulated by the secretion of specific BMP antagonists, which have been shown to physically bind and sometimes be blocked by the extracellular proteoglycan heparan sulphate side chains (from hereon referred to as HS). The purpose of this study was to investigate if local application of 5 µg of HS proteoglycan to a bone regenerate site in a mouse model of distraction osteogenesis (DO) can accelerate bone healing and affect the expression of key members of the BMP signaling pathway. DO was performed on the right tibia of 115 adult male wild-type mice. At mid-distraction (day 11), half the group was injected locally with 5 µg of HS, while the other half was injected with saline. The mice were sacrificed at 2 time-points: mid-consolidation (34 days) and full consolidation (51 days). The distracted tibial zone was then collected for analysis by μCT, radiology, biomechanical testing, immunohistochemistry, and histology. While μCT data showed no statistically significant difference in bone formation, the results of biomechanical testing in stiffness and ultimate force were significantly lower in the HS-injected bones at 51 days, compared to controls. Immunohistochemistry results also suggested a decrease in expression of several key members of the BMP signaling pathway at 34 days. Furthermore, wound dehiscence and infection rates were significantly elevated in the HS group compared to the controls, which resulted in a higher rate of euthanasia in the treatment group. Our findings demonstrate that exogenous application of 5 µg of HS in the distracted gap of a murine model had a negative impact on bone and wound healing.
ACCESSION #
87624931

 

Related Articles

  • Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis. DeCarlo, Arthur A.; Belousova, Maria; Ellis, April L.; Petersen, Donald; Grenett, Hernan; Hardigan, Patrick; O�Grady, Robert; Lord, Megan; Whitelock, John M. // BMC Biotechnology;2012, Vol. 12 Issue 1, p60 

    Background: Many growth factors, such as bone morphogenetic protein (BMP)-2, have been shown to interact with polymers of sulfated disacharrides known as heparan sulfate (HS) glycosaminoglycans (GAGs), which are found on matrix and cell-surface proteoglycans throughout the body. HS GAGs, and...

  • Overview of Radiology, Histology, and Bone Morphogenetic Protein Expression during Distraction Osteogenesis of the Mandible. Campisi, Paolo; Hamdy, R.C.; Lauzier, D.; Amako, M.; Schloss, M.D.; Lessard, M.L. // Journal of Otolaryngology;Sep/Oct2002, Vol. 31 Issue 5, p281 

    Introduction: Distraction osteogenesis (DO) is a form of in vivo tissue engineering during which an osteotomy and controlled distraction are used to lengthen bone. The molecular signals that govern distraction-induced bone formation have not been fully elucidated. Specifically, the role of bone...

  • Bone morphogenetic protein-3 is a negative regulator of bone density. Daluiski, Aaron; Engstrand, Thomas; Bahamonde, Matthew E.; Gamer, Laura W.; Agius, Eric; Stevenson, Sharon L.; Cox, Karen; Rosen, Vicki; Lyons, Karen M. // Nature Genetics;Jan2001, Vol. 27 Issue 1, p84 

    Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β (TGF-β) superfamily. Many BMPs are produced in bone and show osteogenic activity, suggesting that they may be determinants of bone mass. BMP3 was originally purified from bone as osteogenin, which induces...

  • Bone Morphogenetic Proteins: From Basic Science to Clinical Applications. Reddi, A.H. // Journal of Bone & Joint Surgery, American Volume;Mar2001 Supplement 1 Part 1, Vol. 83-A, pS1-1 

    Discusses the role of bone matrix as a repository of bone morphogenetic proteins (BMP). Purification, cloning and expression of recombinant BMP; Chondrogenesis and cartilage maintenance; BMP family in humans and chromosome location; BMP receptors and smads; Clinical applications of BMP.

  • The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis. Liporace, Frank; Breitbart, Eric; Yoon, Richard; Doyle, Erin; Paglia, David; Lin, Sheldon // Journal of Orthopaedics & Traumatology;Jun2015, Vol. 16 Issue 2, p151 

    Background: Recombinant human bone morphogenetic protein-2 (rhBMP-2) is particularly effective in improving osteogenesis in patients with diminished bone healing capabilities, such as individuals with type 1 diabetes mellitus (T1DM) who have impaired bone healing capabilities and increased risk...

  • Deficiency in Perlecan/HSPG2 During Bone Development Enhances Osteogenesis and Decreases Quality of Adult Bone in Mice. Lowe, Dylan; Lepori-Bui, Nadia; Fomin, Peter; Sloofman, Laura; Zhou, Xiaozhou; Farach-Carson, Mary; Wang, Liyun; Kirn-Safran, Catherine // Calcified Tissue International;Jul2014, Vol. 95 Issue 1, p29 

    Perlecan/HSPG2 (Pln) is a large heparan sulfate proteoglycan abundant in the extracellular matrix of cartilage and the lacunocanalicular space of adult bones. Although Pln function during cartilage development is critical, evidenced by deficiency disorders including Schwartz-Jampel Syndrome and...

  • Biodegradable Poly-D,L-Lactic Acid-Polyethylene Glycol Block Copolymers as a BMP Delivery System for Inducing Bone. Saito, Naoto; Okada, Takao; Horiuchi, Hiroshi; Murakami, Narumichi; Takahashi, Jun; Nawata, Masashi; Ota, Hiroshi; Miyamoto, Shimpei; Nozaki, Kazutoshi; Takaoka, Kunio // Journal of Bone & Joint Surgery, American Volume;Apr2001 Supplement 1 Part 2, Vol. 83-A, pS1-92 

    Background: Bone morphogenetic proteins (BMPs) are biologically active molecules capable of eliciting new bone formation. In combination with biomaterials, these proteins can be used in a clinical setting as bone-graft substitutes to promote bone repair. Collagen from animal sources has...

  • Geometry of Carriers Controlling Phenotypic Expression in BMP-Induced Osteogenesis and Chondrogenesis. Kuboki, Yoshinori; Qiming Jin; Takita, Hiroko // Journal of Bone & Joint Surgery, American Volume;Apr2001 Supplement 1 Part 2, Vol. 83-A, pS1-105 

    Background: The effect of the geometry of extracellular matrices on bone morphogenetic protein (BMP)-induced osteogenesis has not been systematically studied. Geometry is crucially important for the scaffold in bone and joint tissue engineering. The purpose of this study was to elucidate...

  • Bone Induction by BMPs/OPs and Related Family Members in Primates. Ripamonti, Ugo; Ramoshebi, Lentsha Nathaniel; Matsaba, Thato; Tasker, Jacqueline; Crooks, Jean; Teare, June // Journal of Bone & Joint Surgery, American Volume;Apr2001 Supplement 1 Part 2, Vol. 83-A, pS1-116 

    Background: In a series of studies in the primate Papio ursinus, we have examined the capacity of bone morphogenetic proteins (BMPs/OPs) delivered in a variety of biomaterial carrier systems to elicit bone formation in heterotopic and orthotopic sites. In this review, we compare the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics